Delivery Order SPE2DB22D3301-SPE2DB24FZ2EX
Award Date
8/5/24
Potential Completion Date
8/6/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,652,155 units of Ondansetron HCL 8 mg tablets. The firm-fixed-price delivery order, valued at $3,711.94, has a period of performance through November 1, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $14,526.21, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,559,016,525 units of the drug Ondansetron HCl 8 mg tablets. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,565,511,314 units of Ondansetron HCL 8 mg tablets, a prescription medication. The firm-fixed-price contract has a ceiling value of $1,839.70 and is set to expire on August 21, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts by various defense and civilian agencies to supply...
This federal contract award, valued at $5,514.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,066,677 units of Ondansetron HCL 8 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 10, 2024. It is not designated as a set-aside contract. As a leading provider of pharmaceutical products and medical supplies to the U.S. federal government,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,539,699 units of Ondansetron HCL 8 mg tablets. The firm-fixed-price contract has a ceiling value of $2,076.54 and a completion date of March 12, 2025. The award is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $4,415.28, is for the delivery of 4,563,893,893 units of the medication Ondansetron HCL 8 mg tablets. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award, valued at $9,996.23, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,134,913 units of Ondansetron ODT 4 mg Tablets in 30-count packages. This award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for...
This federal contract award, valued at $2,083.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,148,202 units of the pharmaceutical product Ondansetron HCL 8 mg Tablet, with a completion date of May 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,729,059 units of Ondansetron HCL 4 mg tablets. The award is a Delivery Order contract with a Firm Fixed Price pricing type, valued at $27,551.08. The contract has a period of performance through September 10, 2024. Amerisourcebergen, through its Corporate Office division, will provide these essential pharmaceutical products...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,091.36, is for the delivery of 4,566,561,598 units of 8 mg Ondansetron HCL tablets. The award has a firm fixed price and an ultimate completion date of November 29, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...